Devanand Sarkar’s quest to cure liver cancer

When Devanand Sarkar, Ph.D., came to VCU Massey Cancer Center in 2008, he wanted to pursue a new direction in his research. Driven by the loss of a close friend and colleague, Sarkar was on a mission to better understand the processes that drive the development of liver cancer. Nearly a decade later, his research is close to bringing about new treatments for the disease while redefining how obesity is connected to cancer.

In America, one of the biggest drivers of liver cancer is fatty liver disease due to obesity. Obesity leads to the deposition of fat in the liver, which causes chronic inflammation and eventually develops into cancer. The mechanisms behind this transformation were once a mystery, and then Sarkar unraveled them.

“It started with this gene, AEG-1,” said Sarkar, the associate director for education and training at Massey who also holds the Harrison Foundation Distinguished Professorship in Cancer Research and is a member of Massey’s Cancer Molecular Genetics research program.

Sarkar and his colleagues had originally discovered and cloned AEG-1 at Columbia University in the laboratory of Paul Fisher, Ph.D., now professor and chair of the Department of Human and Molecular Genetics at VCU School of Medicine.

Read more.